Evidence map›Paper›PMID 36971893›Full record

ArticleMedical oncology (Northwood, London, England)2023

Determination of Rutin's antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathway.

Seher Yılmaz, Züleyha Doğanyiğit, Aslı Okan Oflamaz, Şükrü Ateş, Evrim Suna Arıkan Söylemez, Mehtap Nisari, Ammad Ahmad Farooqı

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Seher YılmazDepartment of Anatomy, Faculty of Medicine, Yozgat Bozok University, 66100, Yozgat, Turkey. sehery38@hotmail.com.ORCID http://orcid.org/0000-0003-4551-995X
Züleyha DoğanyiğitDepartment of Histology and Embriology, Faculty of Medicine, Yozgat Bozok University, 66100, Yozgat, Turkey.ORCID http://orcid.org/0000-0002-6980-3384
Aslı Okan OflamazDepartment of Histology and Embriology, Faculty of Medicine, Yozgat Bozok University, 66100, Yozgat, Turkey.ORCID http://orcid.org/0000-0001-8152-7338
Şükrü AteşDepartment of Anatomy, Faculty of Medicine, Yozgat Bozok University, 66100, Yozgat, Turkey.ORCID http://orcid.org/0000-0001-7096-2481
Evrim Suna Arıkan SöylemezDepartment of Medical Biology, Faculty of Medicine, Afyonkarahisar Health Sciences University, 03100, Afyon, Turkey.ORCID http://orcid.org/0000-0002-8550-793X
Mehtap NisariDepartment of Anatomy, Faculty of Medicine, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-1126-7478
Ammad Ahmad FarooqıInstitute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan.ORCID http://orcid.org/0000-0003-2899-5014
Yozgat Bozok Üniversitesi · TRAfyonkarahisar Sağlık Bilimleri ÜniversitesiErciyes University · TRInstitute of Biomedical and Genetic Engineering · PK

Funding

Bozok Üniversitesi 6602c-TF/21-480
6 · The paper itself

Abstract

Rutin is one of the flavonoids found in fruits and vegetables. The PI3K/AKT/mTOR signaling pathway is critical for the life cycle at the cellular level. In current study, we purposed to demonstrate the antitumoral effect of rutin at different doses through the mTOR-signaling pathway and argyrophilic nucleolar regulatory region. EAC cells were injected subcutaneously into the experimental groups. 25 and 50 mg/kg Rutin were injected intraperitoneally to the animals with solid tumors for 14 days. Immunohistochemical, Real-time PCR and AgNOR analyzes were actualized on the taken tumors. When the rutin given groups and the tumor group were compared, the tumor size increase was detected to be statistically significant (p < 0.05). In immunohistochemical analysis, a significant decrease was encountered in the AKT, mTOR, PI3K and F8 expressions especially in the groups administered 25 mg Rutin, in comparison with the control group (p < 0.05). AgNOR area/nuclear area (TAA/NA) and average AgNOR number were determineted, and statistically important differences were detected between the groups in terms of TAA/NA ratio (p < 0.05). There were significant statistical differences between the mRNA quantity of the PI3K, AKT1 and mTOR genes (p < 0.05). In the in vitro study, cell apoptosis was evaluated with different doses of annexin V and it was determined that a dose of 10 µg/mL Rutin induced apoptosis (p < 0.05). In our study, it was demonstrated in vivo and in vitro that Rutin has an anti-tumor effect on the development of solid tumors formed by both EAC cells.

Indexed as

NeoplasmsProto-Oncogene Proteins c-aktAnimalsAntigens, NuclearApoptosisCell ProliferationPhosphatidylinositol 3-KinasesRutinSignal TransductionTOR Serine-Threonine KinasesAntigens, Nuclearnucleolar organizer region associated proteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRutinTOR Serine-Threonine KinasesAnnexin VEhrlich ascites carcinomamTORPI3KRutin

Identifiers

PMID36971893
OpenAlexW4361001263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.